July 21, 2016 6:48am
…Is more than a fantasy film but, a story of a share price’s life
In managing the market, the beast must win back investor confidence or otherwise remain undervalued and a share pricing “pariah”
… Many changes need to be made in the structure of a company’s story going forward, necessitating transparency and re-purposing of communication
I answer one question; in which company should investors put, keep and commit their money!
Where is today’s market going – subscribe and find out!
Companies in the headlights: JUNO, KITE, PSTI and XON
Indexes and ETFs: The IBB (+0.02%) and the XBI (+0.29%) are UP and the IWM (-0.13%) and the XLV (-0.16%) are DOWN
Dow futures are DOWN -0.11% and NASDAQ futures are -0.03%
U.S. stock index futures indicated a small drop at the open on Thursday as traders eyed a raft of both earnings and data.
European stocks traded lower as markets await the latest monetary policy decision from the European Central Bank (ECB) and digest a slew of earnings from major corporates.
Asia markets mostly gained, with Japanese shares advancing after local media reports suggested the government was preparing a sizable stimulus package.
Data docket: initial claims and the Philly Fed index are set to come out at 8:30 a.m. ET. The FHFA home price index follows on at 9:00 a.m., with leading indicators and existing home sales due at 10:00 a.m.
The stem, cell, gene and regenerative therapy (SCG&RT) sector closed POSITIVE on Wednesday, NEGATIVE on Tuesday, POSITIVE on Monday and Friday and NEGATIVE last Thursday.
The SCG&RT sector’s record after the last 5 days (of 43 covered companies):
- Wednesday closed POSITIVE with 15 decliners, 26 advancers and 2 flats;
- Tuesday closed NEGATIVE with 34 decliners, 7 advancers and 2 flats
- Monday closed POSITIVE with 18 decliners, 24 advancers and 1 flat;
- Friday closed POSITIVE with 13 decliners, 29 advancers and 1 flat;
- Last, Thursday closed NEGATIVE with 22 decliners, 16 advancers and 5 flats
Remembering Wednesday’s post, “It’s happening – the sector is up but, for how long, I hate being the “nabob of negativism” before another oversold daily cycle happens – again!”
- It’s NOT unusual when a daily high collapses, following a previous day’s negative close; however, when a strong positive close is followed by another - you see traders fingering the keys to trigger a new high to collapse.
The reality is you have a good day’s high with moderately low volume and the set-up is in for a decline.
It’s a trading sector and expectation driven market!
You’ve made it to the office, turned on the monitor, having just gotten your coffee and it hits you - what could be today’s trades?
Watch list:
- The iShares Nasdaq Biotechnology (IBB) closed Wednesday up +2.43% and is UP +0.02% in Thursday’s pre-market;
- The SPDR S&P Biotech ETF (XBI) closed Wednesday up +3.37% and is UP +0.29% in Thursday’s pre-market;
- The Health Care Select Sector SPDR ETF (XLV) closed up Wednesday +0.91% and is DOWN -0.16% in Thursday’s pre-market;
- The iShares Russell 2000 (IWM) closed Wednesday up +0.65% and is DOWN -0.13% in Thursday’s pre-market.
Companies in my spotlight:
Intrexon (XON) closed UP +41.47 to $24.55 and the aftermarket indication is -$0.05 – SELL;
Juno Therapeutics (JUNO) closed UP +$1.18 to $28.65 and the aftermarket indication is +$0.24 - BUY.
Kite Pharma (KITE) closed UP +$2.45 to $49.82 and the aftermarket indication is +$0.19 – BUY;
Pluristem (PSTI) closed UP +$0.04 to $1.53. PSTI has extended itself for six (6) sessions and $0.09 in the past four (4) having seen $1.31 on 7/6/16 – SELL:
Whether information or intelligence is good, bad or somewhere in between; I put into context what is relevant and useful for investors.
Henry McCusker, the editor and publisher of RegMed Investors does not hold or have positions in securities referred to in this publication.
